HAEMONETICS CORP (HAE)
Health Care · Medical device manufacturing - blood and plasma collection technologies · NYSE
Haemonetics provides automated plasma collection systems, blood processing devices, and hospital blood management technologies serving plasma centers, blood banks, and hospitals globally.
What HAEMONETICS CORP does
Haemonetics is a global medical technology company offering automated plasma collection systems and donor management software for plasma centers, blood collection and processing devices for blood centers, and hospital technologies including vascular closure, sensor-guided, esophageal protection, hemostasis management, cell salvage, and transfusion management products. The company operates three main segments: Plasma (source plasma collection for pharmaceutical manufacturers), Blood Center (plasma and component collection for blood centers), and Hospital (interventional and blood management technologies).
Themes: ["Plasma collection / source plasma","Blood center operations","Hospital blood management","Vascular interventional technologies","Donor management software","Apheresis collection devices","Hemostasis / transfusion management"]
Fundamentals
- Price$75.00 as of 2026-07-09 close
- Market cap$3.4B as of 2026-07-10
- 1-year return-3.3% as of 2026-07-09 close
- P/E34.85 as of 2026-07-10
- Net margin+7.3% as of 2026-07-10
- Gross margin+59.0% as of 2026-07-10
- ROE+11.3% as of 2026-07-10
- Debt / equity1.54 as of 2026-07-10
- Revenue growth (YoY)-2.0% as of 2026-07-10
- Revenue CAGR (3y)+4.5% SEC XBRL
- Beta0.54 as of 2026-07-10
Key risks (from latest filing)
["Dependence on biopharmaceutical companies (Grifols, Octapharma, Takeda, CSL) as major customers in the Plasma segment, which represent significant concentration risk","Declining net revenues year-over-year (-1.97% YoY) and challenging market conditions in the Blood Center business segment","Regulatory approval and clearance requirements that vary by country and may restrict product availability and distribution"]
Competitors & peers
- Grifols (plasma collection and biopharmaceutical manufacturing)
- Octapharma (plasma collection and biopharmaceutical manufacturing)
- Takeda/BioLife Plasma (plasma collection)
- CSL Limited (plasma collection and biopharmaceutical manufacturing)
- Becton Dickinson (blood collection and processing devices)
- Fresenius (apheresis and blood management)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.